(and dosage form):
Each tablet contains:
Nitroxoline (8-Hydroxy-5-nitroquinoline) 100 mg
A. 18.5 Urinary tract antiseptics.
Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections.
Following oral administration peak plasma concentrations are achieved in 2-3 hours and maximum urinary concentrations in 4-5 hours.
Acute and chronic uncomplicated lower urinary tract infection.
Anuria. Safety in pregnancy and during breast-feeding has not been established.
DOSAGE AND DIRECTIONS FOR USE:
Four to six tablets per day in divided doses, preferably after meals. Treatment should be continued for at least 7 days.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Gastrointestinal disturbances can occur. These can be minimised by administration after meals. The urine of patients taking NICENE®-N is coloured yellow and readily stains skin and clothing.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Symptomatic and supportive treatment should be given.
NICENE®-N Tablets are round, light-green sugar-coated tablets.
Containers of 42 and 500 tablets.
Store below 25°C. Protect from moisture. Keep out of reach of children.
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Adcock Ingram Limited
Adcock Ingram Park
17 Harrison Avenue, Bryanston Ext. 77
Private Bag X69, Bryanston, 2021
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
10 May 1974
Under licence from:-
Laboratories Fournier, Paris
New addition to this site: April 2004
Source: Pharmaceutical Industry
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2004